Objective: This study compared outcomes of standard fenestrated endovascular aneurysm repair (St-FEVAR) with renal artery fenestrations only with more complex FEVAR (Co-FEVAR) with additional fenestrations for the superior mesenteric artery or the celiac trunk, or both.
Fenestrated endovascular abdominal aortic aneurysm (AAA) repair (FEVAR) is being increasingly applied for the treatment of anatomically suitable short-necked, juxtarenal, and suprarenal aortic aneurysms. High-volume centers have reported excellent perioperative and midterm outcomes. [1] [2] [3] [4] Stent graft configuration with regard to the number of fenestrations depends on the desired proximal landing zone. Standard FEVAR (St-FEVAR), usually fitting two fenestrations for the renal arteries and a scallop for the superior mesenteric artery (SMA), was the configuration first used in the treatment of short-necked and some juxtarenal AAAs. FEVAR for more complex anatomy (Co-FEVAR), with extension of disease at the level of renal arteries or higher and a stent graft design fitting three or four fenestrations for the renal arteries, the SMA, and the celiac trunk, became later available to achieve adequate proximal sealing.
Co-FEVAR could have potential advantages for the durability of the repair because it lands higher in the aorta and lengthens the proximal sealing zone. Obviously, Co-FEVAR requires more complex stent graft planning and represents a more complex procedure. It also adds to the imaging requirements, because lateral viewing is needed for catheterization and stenting of the visceral arteries. The complexity may result in higher perioperative mortality and morbidity as a result of the longer operative time, prolonged catheter and wire manipulations, increased blood loss, increased contrast use, and increased coverage of segmental arteries and associated spinal cord ischemia (SCI). 5 The present study investigated whether stent graft design complexity affects perioperative outcomes of FEVAR in a high-volume endovascular center.
METHODS
The study included all consecutive patients treated with FEVAR for short-necked, juxtarenal, or suprarenal aortic aneurysm under the guidance of the senior author (E.L.G.V.) between January 2010 and July 2016. FEVAR as a technique was approved by the Paracelsus Medical University Ethical Committee. Patient informed consent was not required for this study.
Patient data were analysed in two groups by the complexity of the stent graft configuration. The St-FEVAR group consisted of patients who had renal artery fenestrations only, with a most common configuration of two fenestrations for the renal arteries and a scallop for the SMA. The Co-FEVAR group consisted of patients with more complex stent graft design with additional fenestrations for the SMA or the celiac trunk, or both.
The analysis did not exclude patients with previous failed EVAR or open abdominal aortic surgery. Patients with type IV thoracic AAAs treated with fenestrated and branched techniques have been reported elsewhere and were excluded from the present report. 6 Data were collected in a prospectively maintained database.
Aneurysm morphology was assessed by thin-cut (#1.5 mm) spiral computed tomography angiography (CTA) with axial and coronal/sagittal reconstructions. The main indication for FEVAR included absent or too short proximal neck for standard EVAR in an AAA of $50 mm in diameter. AAAs <50 mm with a coexistent iliac aneurysm $35 mm were also treated. The physical status of patients was assessed preoperatively with the American Society of Anesthesiologists (ASA) Physical Status Classification score.
Stent grafts. Stent grafts were customized based on the Zenith system (William A. Cook Australia, Ltd, Brisbane, Queensland, Australia) fitting fenestrations and scallops for the visceral vessels according to preoperative CTA measurements. 7, 8 Most commonly a composite three-part system was used, consisting of a proximal fenestrated tube, a distal bifurcated component, and a contralateral limb. In selected cases of limited working length distally (eg, previous bifurcated surgical graft or EVAR), a fenestrated cuff only was used.
Procedure. All procedures were performed in an angiography suite or a hybrid operating room with a fixed imaging system. All stent grafts were implanted under general anesthesia.
Patients were usually admitted one day before the procedure, unless prehydration or cardiac evaluation was considered necessary.
Surgical access was performed with a bilateral femoral cutdown. Double purse string sutures of 4-0 Prolene (Ethicon, Somerville, NJ) fitted with a snugger were used to allow removal of the delivery system of the proximal body completely while the target vessels were stented from the contralateral side. This helped restore blood flow to the ipsilateral limb as early as possible. Only a stiff guidewire was kept in position to secure safe introduction of the bifurcated graft later. The stent graft deployment technique for fenestrated stent grafts has been previously described in detail. 8, 9 Postoperative management. Patients were monitored postoperatively with clinical and laboratory examinations, including abdominal X-ray imaging in four standardized anteroposterior and oblique views, as reference before discharge. CTA controls were performed at 1 month, 1 year, and thereafter, depending on each patient's characteristics after discussion in the group aiming to reduce the burden of CTAs. Upon suspicion of endoleak or branch vessel malperfusion, additional duplex subtraction angiography for further evaluation and possible reintervention was performed.
Definitions and data analysis. Technical success was defined as successful deployment of the planned stent grafts with patent target vessels and absence of type I or III endoleak at the first postoperative CTA. Initial clinical success was defined as successful deployment of the stent grafts at the intended location without death as a result of aneurysm-related treatment, type I or III endoleak, graft infection or thrombosis, aneurysm rupture, or conversion to open repair #30 days. 10 SCI was defined as any new neurologic deficit at the lower limbs not attributable to another pathologic change. Paraplegia was defined as complete inability to move the lower limbs. 11 Perioperative renal function deterioration was defined as a rise of serum creatinine of >30% from preoperative levels. Data were analyzed using SPSS 22 software (IBM Corp, Armonk, NY). Variables are presented as mean 6 standard deviation. The c 2 test was applied for categoric variables. One-way analysis of variance was used for continuous data. Statistical significance was set at P < .05. Outcomes compared between the St-FEVAR and Co-FEVAR groups included technical success, operative time, estimated blood loss, fluoroscopy time, contrast medium use, 30-day mortality, and major complications. Survival, freedom from reinterventions, and target vessel stent patency during follow-up were analyzed with Kaplan-Meier methods and compared using the log-rank test.
RESULTS
Patients. During the study period, 384 patients (345 men; mean age, 72.7 6 7.8 years) were treated with FEVAR for short-necked, juxtarenal, or suprarenal aortic aneurysms. St-FEVAR was used in 199 patients (51.8%) and Co-FEVAR in 185 (48.2%), including 30 patients with a quadruple FEVAR. Distribution of demographic data, comorbidities, and risk factors between the two groups are reported in Table I . The differences between the groups were not statistically significant.
Aneurysm characteristics. Mean aneurysm diameter was 59.9 6 10 mm for the St-FEVAR group and 62 6 10.3 mm for the Co-FEVAR group (not significant). Mean proximal neck length was shorter in the Co-FEVAR group (0.9 6 1.6 mm) than in the St-FEVAR group (2.3 6 2.2 mm; P < .001).
Evolution of stent graft configuration. Stent graft design evolved during the study period toward a more complex configuration. In 2010, Co-FEVAR represented only 19% of all FEVAR procedures, whereas in 2016, 92.1% of FEVAR procedures were Co-FEVAR (P < .001). Operative data. Mean operative time was 135 6 46 minutes for St-FEVAR and 176 6 53 minutes for Co-FEVAR (P < .001). Mean fluoroscopy time was 45 6 17 minutes for St-FEVAR and 57 6 21 minutes for Co-FEVAR (P < .001). Mean estimated blood loss was 273 6 179 mL for St-FEVAR and 293 6 159 mL for Co-FEVAR (P ¼ .38). Iodinated contrast volume used was 142 6 32 mL for St-FEVAR and 154 6 39 mL for Co-FEVAR (P ¼ .004). Technical failure occurred in four patients (2%) in the St-FEVAR group. Catheterization and stenting of one renal artery was not possible in three patients. One patient required intraoperative conversion because a calcified iliac artery ruptured after stent graft introduction and partial deployment.
In the Co-FEVAR group, technical failure occurred in seven patients (3.8%). Catheterization and stenting of one renal artery was not possible in four patients. In one patient, an accessory renal artery was inadvertently catheterized and stented instead of the main renal artery, resulting in permanent dialysis because the patient had only one functional kidney. Difficult catheterization in one patient resulted in dissection of the renal artery, and early occlusion led to deterioration of renal function, with creatinine elevation to 2.4 mg/dL. One patient died intraoperatively of myocardial infarction after a complicated procedure in a "shaggy" aorta with embolization problems. The angiography after renal stenting showed massive embolization, and thrombosuction was performed, but with a suboptimal result. During these manipulations, the patient developed cardiac problems, needed resuscitation, but finally evolved to cardiac arrest. Table II provides an overview of major perioperative complications for both groups. Renal function deterioration was the most common perioperative complication, occurring in nine (4.5%) and 11 (5.9%) patients in St-FEVAR and Co-FEVAR groups, respectively (not significant). Of those patients, two (1%) required dialysis (one temporary) in the St-FEVAR group and one (0.5%) in the Co-FEVAR group. SCI complications occurred in two patients (1.1%) in the Co-FEVAR group. One patient (quadruple FEVAR) developed paraplegia on day 4 postoperatively that improved to paraparesis after cerebrospinal fluid drainage. A second patient (triple FEVAR) presented with lower limb and pelvic hypoesthesia (without motor deficit) on the third postoperative day. Symptoms improved after cerebrospinal fluid drainage and recovered completely #1 month. The mean total hospital stay, including the preoperative admission day(s), was 8.5 6 3.4 days for the St-FEVAR group and 7.9 6 3.6 days for the Co-FEVAR group (P ¼ .38). Co-FEVAR). Estimated survival at 1 and 3 years was 95% 6 1.7% and 83.4% 6 3.6% for St-FEVAR vs 94% 6 2.4% and 89.4% 6 3.5%, respectively, for Co-FEVAR (P ¼ .96; Fig 2, A) . During follow-up, 32 patients (8.4%) died. Two deaths, both in the St-FEVAR group, were aneurysm related. One patient was admitted to another hospital with a symptomatic aneurysm and a large type Ib endoleak. The patient collapsed 3 hours after admission and was treated urgently by open conversion. He died of complications 3 days after the procedure. A second patient died of mesenteric ischemia after SMA stent occlusion. This patient had a St-FEVAR procedure with two fenestrations for the renal arteries and a scallop for the SMA. At the 19-month follow-up visit, the patient was discovered with an asymptomatic SMA occlusion and a high-grade stenosis of the celiac trunk, which were both stented successfully. The patient was admitted 7 months later to another hospital with symptoms of gastroenteritis, and was transferred to our institution a few days later with prolonged irreversible mesenteric ischemia caused by SMA stent occlusion.
During follow-up, 11 target vessels occluded, four in the St-FEVAR group and seven in the Co-FEVAR group (P ¼ .76). These included nine renal arteries in eight patients and two SMAs (one each in the St-FEVAR and Co-FEVAR groups). Bilateral renal artery occlusion resulted in permanent dialysis in one patient. SMA occlusion was symptomatic in one of the two patients (chronic abdominal angina). Both SMA occlusions were successfully recanalized and stented. One of these two SMAs reoccluded 7 months later and led to lethal mesenteric ischemia, as mentioned above. Estimated target vessel patency at 1 and 3 years was 99.2% 6 0.4% and 98.6% 6 0.6% for St-FEVAR vs 98.6% 6 0.6% and 97.9% 6 0.9%, respectively, for Co-FEVAR (P ¼ .48; Fig 2, B) . Reintervention was needed during follow-up in 26 patients (6.8%): 15 in the St-FEVAR group and 11 in the Co-FEVAR group (P ¼ 1.0; Table III) . One patient from the St-FEVAR group required a redo FEVAR/branched (B)EVAR (2 fenestrations, 2 inner branches) to treat a proximal type Ia endoleak. No reintervention was required for type Ia endoleak in the triple and quadruple FEVAR group (P ¼ 1.0). Estimated freedom from reintervention at 1 and 3 years was 97.9% 6 1.2% and 90.5% 6 3.1% for St-FEVAR vs 95.4% 6 2.0% and 89.1% 6 4.2% for Co-FEVAR, respectively (P ¼ .5; Fig 2, C) .
DISCUSSION
FEVAR is being increasingly used for the treatment of complex pararenal aortic aneurysms.
1,2 The number of fenestrations used to create a durable proximal landing zone depends on the required location. Choosing a more proximal landing zone results in the need to add fenestrations to the graft. Stent graft planning becomes more tedious and the procedure itself more complex. This increased complexity may affect operative outcomes. The present study examined whether increasing complexity of the stent graft configuration was associated with increased perioperative risk. A Co-FEVAR configuration was associated with longer procedure and fluoroscopy time and increased use of iodinated contrast, as expected. For the additional SMA and celiac trunk fenestration, fluoroscopy and angiography were needed in lateral projections. Nevertheless, technical success and 30-day mortality rates were not affected. Similarly, perioperative morbidity, including renal, cardiac, and pulmonary complications, was not increased by a more complex stent graft design. Hospital length of stay was also not affected by a higher number of fenestrations. Co-FEVAR with some degree of covering above the celiac trunk was complicated with SCI in two patients, with no SCI occurring in patients in the St-FEVAR group. This difference was not statistically significant (P ¼ .23), but an increased risk for SCI after a longer aortic coverage with Co-FEVAR cannot be excluded and has been reported. 2 Accumulating experience has made triple and even quadruple FEVAR a more standard technique. This probably intuitively led to increased use of Co-FEVAR vs St-FEVAR during the study period aiming for a longer proximal sealing zone, which might reduce the risk of FEVAR failure (proximal endoleak). In the present study, one patient in the St-FEVAR group required a complex redo FEVAR/BEVAR procedure (with two fenestrations and two inner branches) to repair a type Ia endoleak. In retrospect, this patient should probably have been selected for a Co-FEVAR procedure to start with. Up to the latest follow-up, no type Ia endoleak had developed in the Co-FEVAR group. On the one hand, adding a fenestration and a bridging stent in the SMA with Co-FEVAR might be associated with an increased risk for target vessel occlusion or All procedures were performed with a fixed-imaging system in an angiography suite or in a hybrid operating room. A fixed-imaging system offers important advantages, especially for Co-FEVAR, because lateral C-arm projections are required to address the SMA and the celiac trunk. An optimal set-up and imaging equipment may have contributed to the similar rates of technical success, mortality, and morbidity between the two groups in this series.
Other groups have reported FEVAR and BEVAR results with regard to stent graft complexity. reported outcomes in 288 patients from Malmö and Lille and concluded that a more complicated stent graft design did not lead to increased risk for perioperative mortality, as confirmed by our study. In contrast, Patel et al, 5 in a study of 150 patients, showed that operative mortality increased significantly with a more proximal landing zone with complex stent graft configuration. The present study attempted to answer the question whether adding fenestrations for the SMA and occasionally for the celiac trunk increases the perioperative risk of FEVAR. St-FEVAR and Co-FEVAR were both associated with a low perioperative risk; thus, a strategy toward a liberal addition of one extra fenestration for the SMA and a double-width scallop for the celiac trunk to increase the length of the proximal sealing zone might be reasonable. Although St-FEVAR was not associated with significantly increased sealing complications compared with Co-FEVAR during the midterm followup of this series, a longer proximal sealing zone could reduce the risk of proximal sealing problems in the longterm. Some limitations and confounding factors should be taken into account when the results of the present study are interpreted. This series included not only highsurgical risk but also normal-surgical risk patients because FEVAR was proposed as an alternative to open surgery for all suitable patients. The Co-FEVAR group consisted mostly of triple FEVAR cases and only 30 quadruple FEVAR cases. All cases were performed by a team that had passed the initial learning curve; therefore, the outcomes may not be reproducible everywhere. Finally, a type II statistical error cannot be excluded given the low event rate observed in both compared groups.
CONCLUSIONS
In our series, Co-FEVAR was not associated with a higher perioperative risk than St-FEVAR. A liberal approach toward adding one or two extra fenestrations to achieve a durable proximal sealing zone is reasonable whenever needed. 
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